Biosimilar Market worth US$ 7.2 billion 2018 with a CAGR of 26.30%

Other

Source: Biosimilar Market worth US$ 7.2 billion 2018 with a CAGR of 26.30%

The report "Global Biosimilars Market, By Product Type (Human Growth Hormone, Erythropoietin, Monoclonal Antibodies, Insulin, Interferon, Colony Stimulating Factors and Others), By Application (Oncology, Blood Disorders, Growth Hormone Deficiency Applications and Chronic & Autoimmune Applications), and Region - Global Forecast to 2030".